AAAAAA

   
Results: 1-9 |
Results: 9
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia
Authors: Magnusson, MK Meade, KE Brown, KE Arthur, DC Krueger, LA Barrett, AJ Dunbar, CE
Citation: Mk. Magnusson et al., Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia, BLOOD, 98(8), 2001, pp. 2518-2525
Diagnostic utility of flow cytometric immunophenotyping in myelodysplasticsyndrome
Authors: Stetler-Stevenson, M Arthur, DC Jabbour, N Xie, XY Molldrem, J Barrett, AJ Venzon, D Rick, ME
Citation: M. Stetler-stevenson et al., Diagnostic utility of flow cytometric immunophenotyping in myelodysplasticsyndrome, BLOOD, 98(4), 2001, pp. 979-987
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group
Authors: Woods, WG Neudorf, S Gold, S Sanders, J Buckley, JD Barnard, DR Dusenbery, K DeSwarte, J Arthur, DC Lange, BJ Kobrinsky, NL
Citation: Wg. Woods et al., A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group, BLOOD, 97(1), 2001, pp. 56-62
Long-term outcome and prognostic factors in children's cancer group study 2891 for children and adolescents with previously untreated acute myeloid leukemia and myelodysplastic syndrome
Authors: Lange, BJ Smith, FO Kobrinsky, N Buckley, J Howells, W Lee, JW Sanders, JE Neudorf, S Gold, S Barnard, D DeSwarte, J Dusenbery, K Arthur, DC Woods, WG
Citation: Bj. Lange et al., Long-term outcome and prognostic factors in children's cancer group study 2891 for children and adolescents with previously untreated acute myeloid leukemia and myelodysplastic syndrome, HEMAT BLOOD, 40, 2001, pp. 508-518
Optimizing the Military Healthcare System
Authors: Heroman, WM Parkinson, MD Burke, KA Broyles, T Berlingis, F Arthur, DC Burden, R Blum, D Smith, W Fraser, JD Davis, C Wilcox, S
Citation: Wm. Heroman et al., Optimizing the Military Healthcare System, HLTH INF S, 2001, pp. 117-141
Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences - A Children's Cancer Group study
Authors: Bussey, KJ Lawce, HJ Olson, SB Arthur, DC Kalousek, DK Krailo, M Giller, R Heifetz, S Womer, R Magenis, RE
Citation: Kj. Bussey et al., Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex-, age-, site-, and histopathology-related differences - A Children's Cancer Group study, GENE CHROM, 25(2), 1999, pp. 134-146
Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosisof infants with t(4;11) - a report of the Children's Cancer Group
Authors: Heerema, NA Sather, HN Ge, J Arthur, DC Hilden, JM Trigg, ME Reaman, GH
Citation: Na. Heerema et al., Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosisof infants with t(4;11) - a report of the Children's Cancer Group, LEUKEMIA, 13(5), 1999, pp. 679-686
A high-frequency thermal power comparator
Authors: Budovsky, I Gibbes, AM Arthur, DC
Citation: I. Budovsky et al., A high-frequency thermal power comparator, IEEE INSTR, 48(2), 1999, pp. 427-430
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group
Authors: Heerema, NA Sather, HN Sensel, MG Liu-Mares, W Lange, BJ Bostrom, BC Nachman, JB Steinherz, PG Hutchinson, R Gaynon, PS Arthur, DC Uckun, FM
Citation: Na. Heerema et al., Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group, BLOOD, 94(5), 1999, pp. 1537-1544
Risultati: 1-9 |